Latest news
EyePoint, Inc. Stock 12‑Month Price Target Cut to $40.86, Implies 234% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:17 GMTEyePoint, Inc. 2Q 2026: Revenue $507K, Net loss $(94.47M), EPS $(1.09) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:11:00 GMTEyePoint Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 12:49:24 GMTEyePoint Pharmaceuticals Q2 revenue drops on lower license income - TradingViewTradingView · Wed, 05 Aug 2026 11:24:13 GMTEyePoint reports Q2 loss of $94.5M, cash and investments $180M; LUGANO topline due Aug 2026 - TradingViewTradingView · Wed, 05 Aug 2026 11:13:00 GMTPrice to earnings forward of EyePoint, Inc. – NASDAQ:EYPT - TradingViewTradingView · Fri, 31 Jul 2026 22:35:19 GMT